A standard approach, followed by others, to provide this treatment would cost between 600 million to USD2.7 billion which would increase the cost to patients significantly. In addition, a collaboration would take away the charitable control of this technology.

The safety checks of this therapy has been done in the spirit of standard regulatory authorities procedures, including toxicological studies, pre-clinical, clinical and good manufacturing procedures.

As soon as we have collected enough money, and made an agreement with a country to  establish a clinic while maintaining our independence, the bio-robot team will be ready to treat patients.

​

.